Back to Search
NORMAN SIMON, D.O.
D.O.
Rheumatology Physician
NPI: 1932266897IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
OP 60474745(WA)118946(MO)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 1987
Research & Publications (20)
Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse.
PMID 19371501·J Clin Psychiatry·2009
6-review
Open-label support for duloxetine for the treatment of panic disorder.
PMID 19228176·CNS Neurosci Ther·2009
8-other
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.
PMID 18246327·Psychopharmacology (Berl)·2008
4-observational
Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief.
PMID 18336918·Psychiatry Res·2008
4-observational
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
PMID 18348595·J Clin Psychiatry·2008
3-trial
A detailed examination of cytokine abnormalities in Major Depressive Disorder.
PMID 17681762·Eur Neuropsychopharmacol·2008
8-other
Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder.
PMID 16820212·J Affect Disord·2007
8-other
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
PMID 16581033·Biol Psychiatry·2006
4-observational
The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance.
PMID 17164635·J Nerv Ment Dis·2006
4-observational
Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder.
PMID 17068858·Depress Anxiety·2006
3-trial
An open-label trial of risperidone augmentation for refractory anxiety disorders.
PMID 16649823·J Clin Psychiatry·2006
3-trial
Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
PMID 16640454·Clin Pharmacokinet·2006
3-trial
The implications of medical and psychiatric comorbidity with panic disorder.
PMID 15842182·J Clin Psychiatry·2005
6-review
Complicated grief and its correlates in patients with bipolar disorder.
PMID 16187766·J Clin Psychiatry·2005
4-observational
Loosely bound oxytetracycline in riverine sediments from two tributaries of the Chesapeake bay.
PMID 15952351·Environ Sci Technol·2005
7-preclinical
Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states.
PMID 15894380·J Affect Disord·2005
8-other
End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.
PMID 15726579·Mov Disord·2005
3-trial
Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
PMID 15569893·Am J Psychiatry·2004
3-trial
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
PMID 15349007·J Clin Psychopharmacol·2004
4-observational
Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria.
PMID 12540528·Br J Pharmacol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1035 BELLEVUE AVE STE 500
SAINT LOUIS, MO 63117 - Phone
- (314) 925-4770
Quick Facts
- NPI
- 1932266897
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile